GHRL and type 2 diabetes mellitus: It has been suggested that, in obese T2D patients, UAG may exert its actions in a receptor-independent way by decreasing the AG/DAG ratio and modulation of the systemic AG concentration, attributing the DAG effect to the integration of total ghrelin levels, at least in part [67,68,69].